<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04657718</url>
  </required_header>
  <id_info>
    <org_study_id>CIPS635841</org_study_id>
    <nct_id>NCT04657718</nct_id>
  </id_info>
  <brief_title>CLAIM: Using the KODEX-EPD System to Guide PaCing Lead Placements, A First In Man Study.</brief_title>
  <acronym>CLAIM</acronym>
  <official_title>CLAIM: Using the KODEX-EPDTM System to Guide PaCing Lead Placements, A First In Man Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EPD Solutions, A Philips Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EPD Solutions, A Philips Company</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center (2-3 sites), non-randomized, open label, single arm 3 phase study:&#xD;
&#xD;
        1. Phase 1 or Evaluation Phase: Where the KODEX-EPD System will be used to exclusively&#xD;
           monitor the entire implantation procedure; the KODEX-EPD system will not be used for&#xD;
           guidance during the lead implantation workflow.&#xD;
&#xD;
        2. Phase 2 - KODEX-EPD-assisted Phase: Where the KODEX-EPD system will be used for cardiac&#xD;
           imaging acquisition, guidance during lead implantation in conjunction with fluoroscopic&#xD;
           imaging&#xD;
&#xD;
        3. Phase 3 - KODEX-EPD-guided Phase: Where the KODEX_EPD System will be used as the leading&#xD;
           imaging modality during the lead implantation workflow. Fluoro can be used;&#xD;
&#xD;
             -  up until the part of the lead implantation workflow that is the scope of this&#xD;
                investigation.&#xD;
&#xD;
             -  As a bailout, when the operator declares failure to attempt.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety Endpoint - Incidence of intra -and Perioperative complications</measure>
    <time_frame>3 months</time_frame>
    <description>Incidence rate of intra -and Perioperative complications (bleeding, hematoma, cardiac tamponade, cardiac perforation , appearance of hemodynamic relevant arrhythmias requiring intervention)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Feasibility Endpoint - Ability of imaging with permanent implantable leads and guidewires.</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>The successful use of permanent implantable leads and guidewires for imaging with KODEX - EPD. Assessment of the ability of the KODEX-EPD system to create real time 3D images of the anatomy of the heart.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Right heart image</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Number of patients in whom it is possible to construct a right heart endocardial image, including visualization of right atrial appendage, tricuspidal valve, coronary sinus ostium, and coronary veins in case of CRT device implantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lead implantation adjusted with Fluoroscopy</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Number of patients in whom lead implantation needs to be fluoroscopically adjusted after KODEX-EPD-guided implantation because of 1) inability to overcome anatomical obstacles; 2) mechanical instability including spontaneous dislodgement; 3) unsatisfactorily electrical parameters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Total fluoroscopy time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Contrast</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Total amount of contrast used, if any.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Time - per lead</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Time to final placement, for each implanted lead (from lead introduction into sheath to final placement)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Time - all leads</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Total lead(s) implantation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Total implantation time (skin-to-skin)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy dose</measure>
    <time_frame>time of procedure - 2-5 hours</time_frame>
    <description>Total fluoroscopy dose</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cardiac Arrhythmia</condition>
  <arm_group>
    <arm_group_label>All subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The KODEX-EPD system will be used in combination with leads to image during all procedures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>KODEX-EPD system</intervention_name>
    <description>Cardiac pacing leads implantation for PM, ICD, CRT, HBP and LBBP</description>
    <arm_group_label>All subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patients scheduled to undergo lead placement for cardiac pacing. Subjects who meet all&#xD;
        eligibility criteria and give written informed consent will be enrolled in the study.&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject must be aged &gt;18 years.&#xD;
&#xD;
          2. Subject must have signed a written iInformed Cconsent form to participate in the&#xD;
             study, prior to any study related procedures.&#xD;
&#xD;
          3. Subject must be willing to comply with the protocol requirements.&#xD;
&#xD;
          4. Subject is scheduled for a de novo pacing lead implantation or system upgrade .&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients for whom previous CRT or conduction pacing implantation has failed.&#xD;
&#xD;
          2. Patients considered for leadless cardiac pacing system.&#xD;
&#xD;
          3. Patients undergoing a system revision for infection or malfunction.&#xD;
&#xD;
          4. Patients undergoing planned, urgent or emergency lead revision or lead extraction.&#xD;
&#xD;
          5. Subjects who have received or will receive an experimental drug or used an&#xD;
             experimental medical device within 30 days before the planned start of treatment.&#xD;
&#xD;
          6. Patients included in a clinical registry or clinical trial for an investigational&#xD;
             product.&#xD;
&#xD;
          7. Pregnant women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 17, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>December 1, 2020</last_update_submitted>
  <last_update_submitted_qc>December 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pacing Lead implantation</keyword>
  <keyword>KODEX-EPD</keyword>
  <keyword>CRT</keyword>
  <keyword>His bundle pacing</keyword>
  <keyword>LBBP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

